Stocksigma LogoStocksigma Logo

Sai Life Sciences Reports Q2 FY27 Results and Senior Management Additions

Sai Life Sciences approved its Q2 FY27 results, reporting consolidated revenue from operations of ₹6,585.85m, up 22.5% YoY (vs ₹5,374.70m in Q2 FY26) and

Sai Life Sciences Reports Q2 FY27 Results and Senior Management Additions

Sai Life Sciences Ltd · Change in Management · 06 Nov 2026, 4:35 am

Sai Life Sciences Reports Q2 FY27 Results and Senior Management Additions Sai Life Sciences approved its Q2 FY27 results, reporting consolidated revenue from operations of ₹6,585.85m, up 22.5% YoY (vs ₹5,374.70m in Q2 FY26) and 18.8% QoQ. Consolidated net profit reached ₹983.17m, rising 17.3% YoY and 34.2% QoQ, with diluted EPS at ₹4.58. The board approved key senior management appointments effective 5th Nov'26: Sidhartha Das (SVP & Head HR), Vijay Kumar Suthari (VP - Head Quality & Regulatory Affairs), and Sriram Gopalakrishnan (SVP - Corporate Communications). Additionally, 108,005 equity shares were allotted under ESOP schemes.

Original exchange filing (PDF)

More announcements from Sai Life Sciences Ltd

All Sai Life Sciences Ltd announcements